|
인쇄하기
취소
|
Korean bone implant product passed through FDA's pre-marketing review.
Published: 2004-06-28 06:58:00
Updated: 2004-06-28 06:58:00
Oscotech locally developed BBP, a dental bone implant material, in 1999 and obtained the approval of the U.S. FDA's 510K (Pre-marketing review notification), which was the 2nd event in passing through the U. S. FDA's review after the dental implant.
Oscotech said "The quality system of BBP was renovated to get FDA's approval during the past 3 years and we finally succeeded in obtaining the a...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.